Baseline Therapeutics
PrivateCompany Overview
Baseline Therapeutics is a biotechnology company developing GLP-1 receptor agonist therapeutics for the treatment of addiction disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologyGLP-1 receptor agonistsubstance use disorderaddiction medicinealcohol use disorderAUDclinical trialsdrug developmentGLP-1addiction treatmentpharmacotherapyweight loss drugbiotech startup
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Baseline Therapeutics Comparables
Compare Baseline Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tempero Bio | 81% | |
| Clearmind Medicine Inc. | 76% | |
| Adial Pharmaceuticals, Inc. | 75% | |
Baseline Therapeutics Funding Rounds
Historical fundraising activity
Baseline Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Baseline Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersSan Francisco, California
Employee Range6
Year Founded2026
Last Funding—
See something wrong or outdated?